Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Tilray shares dropped 5.3% amid mixed technical signals, despite sector-wide optimism over potential marijuana reclassification.
Tilray Brands (TLRY) shares fell 5.27% to $11.51 on Monday, reversing recent gains despite a 39% surge in trading volume.
The cannabis sector rallied last week on speculation that President Trump may reclassify marijuana as a Schedule III drug, potentially easing federal restrictions.
While Tilray remains below its 50-day and 100-day moving averages, technical indicators show mixed signals with neutral momentum and ongoing bullish MACD momentum.
The stock has a consensus "Hold" rating with a $20.00 average price target.
9 Articles
Las acciones de Tilray cayeron un 5.3% en medio de señales técnicas mixtas, a pesar del optimismo en todo el sector sobre una posible reclasificación de la marihuana.